Use of 852A in Metastatic Cutaneous Melanoma

Update Il y a 4 ans
Reference: NCT00189332

Woman and Man

Extract

Pilot study to test the efficacy of 852A administered intravenously up to 3 times per week for 12 weeks in subjects with inoperable metastatic cutaneous melanoma.


Inclusion criteria

  • Melanoma ,Unresectable Metatstatic Cutaneous Melanoma

Links